Allergy Therapeutics PLC (GB:AGY)
LSE:AGY
Holding GB:AGY?
Track your performance easily

Allergy Therapeutics (AGY) Cash flow

12 Followers

Allergy Therapeutics Cash Flow

GB:AGY's free cash flow for Q4 2022 was £―. For the 2022 fiscal year, GB:AGY's free cash flow was decreased by £-16.49M and operating cash flow was £―. See a summary of the company’s cash flow.
Cash Flow
TTM
Jun 23Jun 22Jun 21Jun 20Jun 19
Operating Cash Flow
-£ -28.88M£ -14.00M£ 8.40M£ 12.48M£ 5.60M
Investing Cash Flow
-£ -4.59M£ -3.00M£ -2.64M£ -2.51M£ -3.35M
Financing Cash Flow
-£ 27.80M£ -2.81M£ -2.03M£ -431.00K£ 9.54M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
-£ 14.85M£ 20.52M£ 40.27M£ 36.96M£ 27.44M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
-£ 6.49M£ 3.00K£ 4.00K£ 1.00K£ 10.60M
Issuance Of Debt
-£ 33.76M£ -2.27M£ -132.00K£ 1.23M£ -651.00K
Repayment Of Debt
-£ -2.24M£ -2.27M£ -757.00K£ -654.00K£ -651.00K
Free Cash Flow
-£ -33.55M£ -17.06M£ 8.40M£ 12.48M£ 5.60M
Domestic Sales
------
Foreign Sales
------
Currency in GBP

Allergy Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis